Evidence map›Paper›PMID 28402949›Full record

ArticleOncotarget2017

Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.

Baozhong Shen, Tao Huang, Yingying Sun, Zhongnan Jin, Xiao-Feng Li

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Recent developments in translational imaging of in vivo gene therapy outcomes.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  2. An evaluation of the physiological uptake range ofFrontiers in veterinary science · 2024
    Article
  3. An Investigation of the Relationship BetweenCurrent radiopharmaceuticals · 2024
    Article
  4. The application ofQuantitative imaging in medicine and surgery · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. The utility of 2-[European radiology · 2021
    Article
  11. Article
  12. Article
  13. [Progress in the clinical application and correlation between glucose transporter-1 andSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Molecular imaging in tracking cancer stem cells: A review.Medical journal of the Islamic Republic of Iran · 2020
    Review
  19. Review
  20. Frontiers in veterinary science · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Baozhong ShenPET/CT/MRI Center, The Fourth Hospital of Harbin Medical University, Harbin, China.
Tao HuangDepartment of Radiology, The Fourth Hospital of Harbin Medical University, Harbin, China.
Yingying SunPET/CT/MRI Center, The Fourth Hospital of Harbin Medical University, Harbin, China.
Zhongnan JinPET/CT/MRI Center, The Fourth Hospital of Harbin Medical University, Harbin, China.
Xiao-Feng LiPET/CT/MRI Center, The Fourth Hospital of Harbin Medical University, Harbin, China.
Fourth Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

18F-fluorodeoxyglucose (18F-FDG) positron emission tomography has become an important tool for detection, staging and management of many types of cancer. Oncology application of 18F-FDG bases on the knowledge that increase in glucose demand and utilization is a fundamental features of cancer. Pasteur effect, Warburg effect and reverse Warburg effect have been used to explain glucose metabolism in cancer. 18F-FDG accumulation in cancer is reportedly microenvironment-dependent, 18F-FDG avidly accumulates in poorly proliferating and hypoxic cancer cells, but low in well perfused (and proliferating) cancer cells. Cancer is a heterogeneous and complex "organ" containing multiple components, therefore, cancer needs to be investigated from systems biology point of view, we proposed the concept of "systems molecular imaging" for much better understanding systems biology of cancer.This article revisits 18F-FDG uptake mechanisms, its oncology applications and the role of 18F-FDG PET for "systems molecular imaging".

Indexed as

Fluorodeoxyglucose F18Positron-Emission TomographyAnimalsCell Line, TumorDisease Models, AnimalFemaleGlucoseHumansHypoxiaMiceMolecular ImagingNeoplasm MetastasisNeoplasmsNeoplasm StagingOxygenPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18GlucoseOxygen18F-FDGcancerglucose metabolismhypoxiapositron emission tomography

Identifiers

PMID28402949
PMCPMC5522167
OpenAlexW2599779877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.